Recurrent Dupuytren’s contracture is common regardless of the initial intervention.
Collagenase clostridium histolyticum (CCH) is approved for treatment of adult patients
with Dupuytren’s contracture with a palpable cord. This study assessed safety and
efficacy of CCH for the retreatment of recurrent contractures in joints that were
previously effectively treated with CCH.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Hand SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
Paper 48
Footnotes
Clinical Paper Session 08: Dupuytren
Friday, September 19, 2014 • 2:13–2:20 PM
Category: Treatment
Keyword: Hand and Wrist, Diseases and Disorders
Identification
Copyright
© 2014 Published by Elsevier Inc.
